Access Official Technical PDF

Share Summary:LinkedInEmail

The IZRL ETF is an exchange-traded fund focused on Israeli companies associated with innovation across several technology-related fields. For industrial automation professionals and business leaders, it may be relevant as an investment vehicle with exposure to industrial and manufacturing businesses alongside information technology, communications and health care. It is not an industrial automation product or a direct measure of factory technology adoption; it is an equity fund designed to track a defined index.

What the IZRL ETF is designed to track

The ARK Israel Innovative Technology ETF (ticker: IZRL) seeks, before fees and expenses, to closely correspond to the performance of the ARK Israeli Innovation Index, identified in the fund materials as IZRLINVN. The index is designed to track exchange-listed companies incorporated and/or domiciled in Israel whose main business operations are associated with disruptive innovation.

The index’s stated areas include genomics, health care, biotechnology, industrials, manufacturing, the Internet and information technology. This broad scope matters when interpreting the fund: industrial and manufacturing exposure is part of a wider innovation-oriented portfolio, rather than the fund’s sole focus. The fund holds equity securities and depositary receipts of eligible exchange-listed companies.

Why industrial technology observers may pay attention

Automation engineers and operations leaders typically assess technology through questions about deployment, integration, reliability and production outcomes. An equity fund answers a different question: how a portfolio provides exposure to companies selected under an index methodology. Still, the IZRL ETF’s inclusion of industrials and manufacturing offers a way to monitor a basket of companies across sectors that may be relevant to technology and industrial innovation.

The fund provider describes three investment rationales: targeted exposure to innovation in Israel, potential growth through companies seeking new opportunities, and diversification relative to traditional indices. These are the provider’s stated objectives and rationale, not guarantees of results. The materials also note that the fund may complement traditional value or growth strategies because of limited overlap with traditional indices.

As of September 30, 2025, the fund’s sector breakdown showed information technology at 52.3%, industrials at 16.8%, communication services at 11.0%, and health care at 10.1%. Consumer discretionary, consumer staples and financials made up the remainder. These figures show that industrials are a meaningful component, but information technology represents the largest share.

Portfolio profile and examples of holdings

At the same reporting date, IZRL had 76 holdings. Its ten largest positions accounted for 22.8% of the portfolio. The listed top holdings included Aryt Industries and Gilat Satellite Networks, each at 2.7%; Tower Semiconductor and Sapiens International, each at 2.4%; and TAT Technologies at 2.3%. Other names among the ten largest included UroGen Pharma, Cellebrite, CyberArk Software, Teva Pharmaceutical Industries and Allot.

Holdings can change, and the fund’s materials caution that listed securities are not investment advice or a recommendation to buy, sell or hold any security. The portfolio should therefore be treated as a dated snapshot, not a permanent roster. The reported weighted average market capitalization was $3 billion and median market capitalization was $1 billion. By capitalization, 54.0% of assets were in small companies, 28.0% in medium-sized companies, 9.1% in large companies, 8.3% in micro-cap companies and none in mega-cap companies.

Geographically, 92.0% of the fund was classified as Africa / Middle East and 8.0% as North America. The fund notes that this breakdown relates principally to the domicile of securities issuers. It should not be read as a precise map of where every company operates or earns revenue.

Understanding costs, performance and risk

The reported net expense ratio was 0.49%, and the fund’s inception date was December 5, 2017. Performance figures in the materials are for periods ended September 30, 2025. They show that returns varied by measurement period and comparison index; past performance does not guarantee future results. Fund returns can differ from index returns, and investors cannot invest directly in an index.

Several risks are especially relevant when evaluating a focused, internationally oriented equity fund:

  • Equity and market risk: Share values may decline because of broad market or economic conditions.
  • Foreign securities risk: Securities of foreign issuers involve risks beyond those associated with U.S. investments.
  • Index tracking risk: The ETF may not match the performance of its underlying index.
  • Technology and innovation risk: Technology companies face competition, while companies developing new technologies may not successfully capitalize on them and may face political or legal challenges.
  • Market-price and NAV differences: ETF shares may trade at prices that differ from net asset value, particularly during periods of market volatility.

The fund materials also identify concentration and non-diversification risks. Investors should review the prospectus for a fuller account of risks, charges and expenses. The stated expense ratio does not include possible brokerage commissions or costs associated with trading shares.

What the fund’s profile means for decision-makers

For industrial technology watchers, IZRL offers a broad equity-market lens on Israeli innovation with a measurable industrials allocation and a larger information technology component. It does not isolate automation suppliers, manufacturing equipment, or any single industrial theme. Its holdings, sector weights and geographic profile are therefore more useful for understanding the fund’s overall exposure than for drawing conclusions about a particular technology market.

Any investment assessment should distinguish the fund’s stated objective from realized performance, and historical results from future expectations. Reviewing the current holdings, index methodology, prospectus and risks is essential before making an investment decision. For operations leaders, the practical takeaway is to treat IZRL as a diversified-by-company but focused-by-market investment vehicle—not as a proxy for operational performance or a direct indicator of industrial adoption.

Access Official Technical PDF

About The Author